Clinical Trial Update: A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

Results from a Phase 2 trial evaluating SURF-100 (mycophenolic acid plus betamethasone sodium phosphate) for dry eye disease have been posted following study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SURF-100 (mycophenolic acid and betamethone sodium phosphate)

Snippet

Sponsor: Surface Ophthalmics, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-03-18